fluconazole has been researched along with Duncan Disease in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Excerpt | Relevance | Reference |
---|---|---|
"We describe a renal transplant recipient, with overimmunosuppression induced by the interaction of tacrolimus and fluconazole, who developed two severe diseases produced by two different viruses of the herpes group (cytomegalovirus [CMV] disease and posttransplant lymphoproliferative [PTLD] disease EBV-related)." | 3.71 | [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime]. ( Alvarez Grande, J; de Oña, M; Fresno, MF; Gómez, E; Herreros, M; Melón, S; Navascués, R; Tricas, L, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morita, K | 1 |
Honda, A | 1 |
Koya, J | 1 |
Toyama, K | 1 |
Ikeda, M | 1 |
Misawa, Y | 1 |
Okugawa, S | 1 |
Nakamura, F | 1 |
Moriya, K | 1 |
Kurokawa, M | 1 |
Gómez, E | 1 |
Melón, S | 1 |
Fresno, MF | 1 |
Tricas, L | 1 |
Navascués, R | 1 |
de Oña, M | 1 |
Herreros, M | 1 |
Alvarez Grande, J | 1 |
2 other studies available for fluconazole and Duncan Disease
Article | Year |
---|---|
Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Ribosomal; Echinocan | 2018 |
[Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Epstein-Barr Virus Infections; Flucon | 2002 |